3-5 days a week in office
AI for biomedical cause & effect discovery
Open for applications
AI for biomedical cause & effect discovery
101-200 employees
Open for applications
3-5 days a week in office
101-200 employees
Causaly’s mission is to accelerate the pace of human discovery in biomedicine and to power the research organizations of the world’s largest life sciences companies to accelerate their drug discovery and development programs.
Jump to section
Causaly’s mission is to accelerate the pace of human discovery in biomedicine and to power the research organizations of the world’s largest life sciences companies to accelerate their drug discovery and development programs.
Few candidates hear
back within 2 weeks
36% female employees
52% employee growth in 12 months
Our generation’s repositories of human knowledge have become massive, and digital, which is why Causaly's solution to boost research productivity has received much acclaim.
Swiss Novartis is Causaly’s first customer, quickly followed by an array of pharma and biotech companies that are leveraging the platform to accelerate their execution.
The company collaborates with strong research labs on developing its Machine Learning algorithm, including UCL, King’s College London and AUEB’s NLP group.
The company's aim is to reach human performance for understanding single sentence causality, as well as to visualise this evidence with network graphs.
Kirsty
Company Specialist at Welcome to the Jungle
Jul 2023
$60m
SERIES B
May 2021
$17m
SERIES A
This company has top investors
Yiannis Kiachopoulos
(CEO)Trained as an Information Technology Consultant at Accenture before working in business development in Germany
Artur Saudabayev
(CTO)Accomplished an M.Sc in Informatics from Edinburgh before working as an Instructor of Robotics at Nazarbayev University
Dan Atkinson (VP People)
Software Engineering
Design
Sales & Account Management